Transitioning to high-value health systems in G20+ countries

Overview

In G20+ countries, health systems are confronted by the common challenges of unsustainable cost increases, rising citizen demand for healthcare, slow adoption of innovation and inequities in access to services and health outcomes. Country health reforms typically aim to deliver “value for money and value for many”: efficient use of resources and high-quality, accessible services for all.

The Health Systems Innovation Lab at Harvard University prepared the report Transitioning to high-value health systems in G20+ countries to contribute to the Global Innovation Hub for Improving Value in Health’s ongoing program of work. This report examined progress made to date by a selection of G20+ countries (Argentina, France, Indonesia, Italy, Republic of Korea, the Russian Federation, Saudi Arabia, Singapore, Türkiye, United States of America) in transitioning to high-value health systems and shared lessons learned. A framework for high-value health systems was introduced, followed by a country-by-country discussion of experiences implemented value-based care and considerations of next steps for health reform for better value.